Variability in opioid prescription monitoring and evidence of aberrantmedication taking behaviors in urban safety-net clinics

Pain

Volumn 156, Issue 2, 2015, Pages 335-340

  Lange, Allison ^a   Lasser, Karen E ^a,b   Xuan, Ziming ^b   Khalid, Laila ^a   Beers, Donna ^a   Heymann, Orlaith D ^a   Shanahan, Christopher W ^a,d   Crosson, Julie ^a,c   Liebschutz, Jane M ^a  

^a BOSTON MEDICAL CENTER   (United States)

^b BOSTON UNIVERSITY   (United States)

^c Department of Adult Medicine   (United States)

^d Mattapan Community Health Center   (United States)

Author keywords

Chronic pain; Primary care; Substance abuse

Indexed keywords

OPIATE; NARCOTIC ANALGESIC AGENT;

ADULT; ARTICLE; DRUG MONITORING; ELECTRONIC HEALTH RECORD; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAID; MEDICARE; PAIN; PATIENT RISK; PRACTICE GUIDELINE; PRESCRIPTION; PRIORITY JOURNAL; SAFETY NET HOSPITAL; URBAN POPULATION; URINALYSIS; CHRONIC PAIN; COHORT ANALYSIS; MIDDLE AGED; PRIMARY HEALTH CARE; PROCEDURES; PROTOCOL COMPLIANCE; RETROSPECTIVE STUDY; STANDARDS;

ANALGESICS, OPIOID; CHRONIC PAIN; COHORT STUDIES; FEMALE; GUIDELINE ADHERENCE; HUMANS; MALE; MIDDLE AGED; PRESCRIPTIONS; PRIMARY HEALTH CARE; RETROSPECTIVE STUDIES; SAFETY-NET PROVIDERS; URBAN POPULATION;

EID: 84977604900     PISSN: 03043959     EISSN: 18726623     Source Type: Journal    
DOI: 10.1097/01.j.pain.0000460314.73358.ff     Document Type: Article

References (23)

1. Interagency Guideline on Opioid Dosing for Chronic Non-cancer Pain. In: AMDG, editor: Washington State American Medical Directors, Olympia, WA. 2010.
2. Ballantyne JC, Sullivan MD, Kolodny A. Opioid Dependence vs Addiction: A Distinction Without a Difference? Arch Intern Med 2012;172:1342-3.
3. Caudill-Slosberg MA, Schwartz LM, Woloshin S. Office visits and analgesic prescriptions for musculoskeletal pain in US: 1980 vs 2000. PAIN 2004;109:514-9.
4. Chou R, Fanciullo GJ, Fine PG, Adler JA, Ballantyne JC, Davies P, Donovan MI, Fishbain DA, Foley KM, Fudin J, Gilson AM, Kelter A, Mauskop A, O'Connor PG, Passik SD, Pasternak GW, Portenoy RK, Rich BA, Roberts RG, Todd KH, Miakowski C. Clinical guidelines for the use of chronic opioid therapy. J Pain 2009;10:113-30.
5. Chou R, Fanciullo GJ, Fine PG, Adler JA, Ballantyne JC, Davies P, Donovan MI, Fishbain DA, Foley KM, Fudin J, Gilson AM, Kelter A, Mauskop A, O'Connor PG, Passik SD, Pasternak GW, Portenoy RK, Rich BA, Roberts RG, Todd KH, Miaskowski C. Clinical guidelines for the useofchronic opioid therapy in chronic noncancer pain. J Pain 2009;10:113-30.
6. Cicero TJ, Kurtz SP, Surratt HL, Ibanez GE, Ellis MS, Levi-Minzi MA, Inciardi JA. Multiple Determinants of Specific Modes of Prescription Opioid Diversion. J Drug Issues 2011;41:283-304.
7. Dunn KM, Saunders KW, Rutter CM, Banta-Green CJ, Merrill JO, Sullivan MD, Weisner CM, Silverberg MJ, Campbell CI, Psaty BM, Von Korff M. Opioid prescriptions for chronic pain and overdose: a cohort study. Ann Intern Med 2010;152:85-92.
8. Gilson AM, Ryan KM, Joranson DE, Dahl JL. A reassessment of trends in the medical use and abuse of opioid analgesics and implications for diversion control: 1997-2002. J Pain Symptom Manage 2004;28:176-88.
9. Green TC, Mann MR, Bowman SE, Zaller N, Soto X, Gadea J, Cordy C, Kelly P, Friedmann PD. How does use of a prescription monitoring program change medical practice? Pain Med 2012;13:1314-23.
10. Inciardi JA, Surratt HL, Cicero TJ, Beard RA. Prescription opioid abuse and diversion in an urban community: the results of an ultrarapid assessment. Pain Med 2009;10:537-48.
11. Johnson H, Paulozzi LJ, Porucznik C, Mack K, Herter B. Decline in drug overdose deaths after state policy changes-Florida, 2010-2012. MMWR Morb Mortal Wkly Rep 2014;26:569-74.
12. Jones CM, Mack KA, Paulozzi LJ. Pharmaceutical overdose deaths, United States, 2010. JAMA 2013;309:657-9.
13. Liebschutz JM, Saitz R, Weiss RD, Averbuch T, Schwartz S, Meltzer EC, Claggett-Borne E, Cabral H, Samet JH. Clinical factors associated with prescription drug use disorder in urban primary care patients with chronic pain. J Pain 2010;11:1047-55.
14. McAuley D. Advanced Opioid Converter. Available at: http://www. globalrph.com/opioidconverter2.htm. Accessed September 9, 2014.
15. Meltzer EC, Rybin D, Meshesha LZ, Saitz R, Samet JH, Rubens SL, Liebschutz JM. Aberrant drug-related behaviors: unsystematic documentation does not identify prescription drug use disorder. Pain Med 2012;13:1436-43.
16. Morasco BJ, Duckart JP, Dobscha SK. Adherence to clinical guidelines for opioid therapy for chronic paininpatients with substance use disorder. J Gen Intern Med 2011;26:965-71.
17. Nuckols TK, Anderson L, Popescu I, Diamant AL, Doyle B, Di Capua P, Chou R. Opioid prescribing: a systematic review and critical appraisal of guidelines for chronic pain. Ann Intern Med 2014;160:38-47.
18. Olsen Y, Daumit GL, Ford DE. Opioid prescriptions by U.S. primary care physicians from 1992 to 2001. J Pain 2006;7:225-35.
19. Paulozzi LJ, Budnitz DS, Xi Y. Increasing deaths from opioid analgesics in the United States. Pharmacoepidemiol Drug Saf 2006;15:618-27.
20. Rigg KK, Kurtz SP, Surratt HL. Patterns of prescription medication diversion among drug dealers. Drugs (Abingdon Engl) 2012;19:144-55.
21. Starrels JL, Becker WC, Weiner MG, Li X, Heo M, Turner BJ. Low use of opioid risk reduction strategies in primary care even for high risk patients with chronic pain. J Gen Intern Med 2011;26:958-64.
22. Warner M, Chen LH, Makuc DM, Anderson RN, Minino AM. Drug poisoning deaths in the United States, 1980-2008. NCHS Data Brief 2011;81:1-8.
23. Willy ME, Graham DJ, Racoosin JA, Gill R, Kropp GF, Young J, Yang J, Choi J, MaCurdy TE, Worrall C, Kelman JA. Candidate metrics for evaluating the impact of prescriber education on the safe use of extended-release/long-acting (ER/LA) opioid analgesics. Pain Med 2014;15:12459.